VISCERAL FAT IS INCREASED IN INDIVIDUALS WITH CROHN'S DISEASE: A COMPARATIVE ANALYSIS WITH HEALTHY CONTROLS.

BACKGROUND It is known that obesity is associated with a chronic inflammatory state, but few studies have evaluated visceral fat (VF) content and its role in individuals with Crohn's disease (CD). OBJETIVE To compare the nutritional status, body composition and proportion of VF between CD individuals and healthy volunteers. METHODS Cross-sectional study that enrolled individuals with Crohn's disease and healthy controls. The stratification according to nutritional status was carried out by means of BMI. The percentage of body fat percentage (%BF) and VF were estimated by means of DEXA. VF proportion was evaluated by means of the VF/BMI and VF/%BF ratios. RESULTS A total of 78 individuals were included. The control group was comprised of 28 healthy subjects aged 35.39±10 years old (60.7% women); mean BMI=23.94±3.34 kg/m2; mean VF=511.82±448.68 g; mean CRP=0.81±1.78 ng/mL. The CD group was comprised of 50 patients; 11 (22%) were underweight (BMI=18.20±1.97 kg/ m2; %BF=24.46±10.01; VF=217.18±218.95 g; CRP=4.12±4.84 ng/mL); 18 (36%) presented normal weight (BMI=22.43±1.48 kg/m2; %BF=30.92±6.63; VF=542.00±425.47 g and CRP=4.40±1.78 ng/mL); 21 (42%) were overweight or obese (BMI=29.48±3.78 kg/m2; %BF=39.91±7.33; VF=1525.23±672.7 g and CRP=1.33±2.06 ng/mL). The VF/BMI ratio was higher in the CD group when compared to controls (32.41±24.63 vs 20.01±16.23 g per BMI point; P=0.02). Likewise, the VF/%BF was also higher in the CD group (35.21±23.33 vs 15.60±12.55 g per percentage point; P<0.001). CONCLUSION Among individuals with Crohn's disease, BMI presents a direct correlation with visceral fat content. These results indicate the presence of an adiposopathy in Crohn's disease subjects, which is evidenced by a higher visceral fat.

[1]  P. Kotze Obesity and Crohn's disease: what comes first, the egg or the chicken? , 2017, Arquivos de gastroenterologia.

[2]  Carlos Augusto Real Martinez,et al.  Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease , 2017, Intestinal research.

[3]  S. Ramamoorthy,et al.  Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes , 2017, Nature Reviews Gastroenterology &Hepatology.

[4]  G. Kaplan,et al.  The Increasing Weight of Crohn's Disease Subjects in Clinical Trials: A Hypothesis-generatings Time-trend Analysis , 2013, Inflammatory bowel diseases.

[5]  C. O'Morain,et al.  High prevalence of overweight and obesity in adults with Crohn's disease: associations with disease and lifestyle factors. , 2013, Journal of Crohn's & colitis.

[6]  E. Riboli,et al.  Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study) , 2013, The American Journal of Gastroenterology.

[7]  Christopher F. Martin,et al.  Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease 12 , 2011, Inflammatory bowel diseases.

[8]  J. Stevens,et al.  Associations between gender, age and waist circumference , 2011, European Journal of Clinical Nutrition.

[9]  B. Bertin,et al.  Obesity, visceral fat and Crohn's disease , 2010, Current opinion in clinical nutrition and metabolic care.

[10]  E. Maury,et al.  Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome , 2010, Molecular and Cellular Endocrinology.

[11]  J. Satsangi,et al.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications , 2006, Gut.

[12]  S. Stockdale An Organizational Update , 2003 .

[13]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[14]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[15]  Abhijeet Yadav,et al.  Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease. , 2017, Inflammatory bowel diseases.

[16]  B. Norrving,et al.  Organizational update: World Health Organization. , 2014, Stroke.

[17]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.